Charlson Comorbidity Index

Related by string. Charlson comorbidity index * : Charlson . Drew Charlson / comorbidity : National Comorbidity Survey . psychiatric comorbidity . Comorbidity Study . Comorbidity / indexing . indexed . INDEX . Indexing . Indexed . indexer : Producer Price Index . Small Cap Index . Germany DAX index . Present Situation Index . Consumer Confidence Index . Shanghai composite index * *

Related by context. All words. (Click for frequent words.) 64 EQ 5D 62 Charlson comorbidity index 62 CHADS2 62 preoperative PSA 61 comorbidity 61 psychiatric comorbidities 61 CORE OM 61 sociodemographic characteristics 61 logistic regression analysis 60 clinico pathological 60 Comorbidity 60 multivariate analyzes 60 BMI z 59 APACHE II 59 clinicopathological 59 Injury Severity Score 59 echocardiographic parameters 59 waist circumference WC 59 comorbid conditions 59 MMSE score 58 NSTEMI 58 multivariable analyzes 58 bivariate analyzes 58 sociodemographic variables 58 multiple logistic regression 58 Rating Scale BPRS 58 nonmetastatic 58 SF #v# 58 electrophysiologic 58 somatoform disorders 58 Risk Stratification 58 Poisson regression 58 interrater reliability 58 postoperative AF 58 NMIBC 57 multivariable analysis 57 Sociodemographic 57 elevated LDH 57 multivessel disease 57 multivariate regression analysis 57 MS DRG 57 nondiabetic patients 57 longitudinal cohort study 57 HRQoL 57 sociodemographic factors 57 Unstable Angina 57 nomograms 57 International Prognostic Scoring 57 pT2 57 APOE genotype 57 obstructive coronary artery 57 depressive symptomatology 57 prostate cancer CaP 57 prognostic variables 57 logistic regression analyzes 57 OSDI 57 IPAH 57 TNM staging 57 multivariate Cox 57 gastric cardia 57 retrospective cohort study 57 generalized estimating 57 EBUS FNA 56 CaPSURE 56 Main Outcome Measure 56 comorbid depression 56 odds ratios ORs 56 % CI #.#-#.# [008] 56 radical prostatectomy RP 56 PSQI 56 retrospectively analyzed 56 BPS IC 56 postoperative complication 56 Carotid Endarterectomy 56 risk reducing salpingo 56 pretest probability 56 tumor histology 56 syndromic 56 SGRQ 56 logistic regression models 56 binary logistic regression 56 euthymic patients 56 stratifying patients 56 Comorbidities 56 Symptom severity 56 Sentinel Lymph Node Biopsy 56 MetS 56 logistic regression model 56 T2DM 56 LV dysfunction 56 MMSE scores 56 neurocognitive function 56 Afib 56 univariate 56 carotid stenosis 56 gallstone disease 56 comorbidities 56 transrectal ultrasound guided 56 diabetes mellitus DM 56 Coronary CTA 56 psychiatric comorbidity 56 oral anticoagulation 56 covariate 56 pancreatic adenocarcinoma 56 T1a 56 prognostic indicators 56 Heritability 55 ASCUS 55 clinicopathologic 55 bivariate 55 immunochemical fecal occult 55 Prognostic 55 histologically proven 55 bronchoalveolar lavage 55 Cardiotoxicity 55 Y BOCS 55 Univariate analysis 55 Coronary Artery Bypass Graft 55 Symptom Severity 55 Univariate 55 diagnosing coronary artery 55 histological subtype 55 Main Outcome Measures 55 MS DRGs 55 Health Assessment Questionnaire 55 cytologic 55 Treatment Outcome 55 ANCOVA 55 neuropsychological assessment 55 prospectively evaluated 55 bladder carcinoma 55 EuroSCORE 55 multivariate logistic regression 55 ankle brachial 55 atherosclerotic renal artery stenosis 55 biopsy Gleason 55 Reynolds Risk Score 55 Score TOS 55 noncardiac 55 confidence intervals CIs 55 cranial irradiation 55 Neurocognitive 55 nonadherent 55 T1c 55 Severity Index 55 intraclass correlation coefficients 55 multivariable Cox 55 acetabular fractures 55 physiologic parameters 55 ECLS 55 DLQI 55 Subgroup analyzes 55 MDRD 55 meta regression 55 NIH CPSI 55 angiographically 55 serum selenium 55 somatization 55 transvaginal sonography 55 DSM IV diagnoses 55 Acute Coronary Syndromes ACS 55 DAS# scores 55 MDRD equation 55 Montgomery Åsberg Depression 54 undergoing coronary angiography 54 coexisting illnesses 54 etiologic 54 Symptom Checklist 54 Myocardial Ischemia 54 HSCT 54 unstable angina UA 54 neurocognitive impairment 54 hematopoietic cancers 54 Stroke Scale NIHSS 54 NYHA functional class 54 preintervention 54 histologic subtype 54 NHAMCS 54 Seattle Angina Questionnaire 54 somatization disorder 54 Glomerular filtration rate 54 interobserver 54 plasma homocysteine 54 colorectal adenoma 54 Kaplan Meier estimates 54 platelet reactivity 54 autonomic dysfunction 54 urine dipstick 54 Chronic Renal Failure 54 convergent validity 54 mammographic density 54 amnestic MCI 54 PROLARIS 54 Congenital Heart Surgery 54 adiponectin concentrations 54 Evaluable 54 hip resurfacing arthroplasty 54 HER2 expression 54 univariate analyzes 54 pT3 54 CT angiograms 54 carotid artery stenting CAS 54 antiarrhythmic drug 54 inflammatory biomarkers 54 Pharmacoeconomic 54 intima media thickness 54 subscore 54 laparoscopic radical nephrectomy 54 estimated GFR 54 Preoperatively 54 confounder 54 intraobserver 54 affective psychosis 54 Functional Assessment 54 extensive metabolizers 54 oncological outcomes 54 gene polymorphism 54 anthropometric measurements 54 Diseases Ninth 54 ICD implantation 54 Histopathological 54 subclinical atherosclerosis 54 β blockers 54 HRQL 54 Status Scale EDSS 54 transcranial Doppler 54 suicide attempters 54 tertiles 54 DRGs 54 CT Angiography 54 obstructive CAD 54 #F FDG PET 54 bone scintigraphy 54 NSTE ACS 54 psychosocial variables 54 recurrent DVT 54 periprocedural 54 urodynamic parameters 54 comorbid disorders 54 Renal Insufficiency 54 multivariable adjusted 54 carotid IMT 54 adolescent idiopathic scoliosis 54 cytogenetic abnormalities 54 comorbid anxiety 54 BI RADS 54 Cockcroft Gault 54 psychiatric outpatients 54 IBDQ 54 non squamous histology 54 osteopathic manipulative treatment 54 CHADS 53 Infarction 53 NIHSS score 53 univariate analysis 53 urothelial carcinoma 53 ratio WHR 53 genetic polymorphisms 53 HRQOL 53 efficacy evaluable 53 subscale scores 53 thrombophilia 53 DAS# remission 53 Logistic regression 53 prostate cancer PCa 53 underwent coronary angiography 53 pretransplant 53 endocrinologic 53 nonalcoholic steatohepatitis NASH 53 magnetic resonance spectroscopic imaging 53 depressive symptom 53 MTWA testing 53 CC genotype 53 atherothrombotic 53 Renal Artery 53 Electroencephalography 53 premorbid 53 radical nephrectomy 53 extracolonic findings 53 leukocyte count 53 Multivariate analysis revealed 53 perfusion CT 53 PCa 53 DVT PE 53 hemodynamic parameters 53 warfarin dosage 53 Thrombolysis 53 Meta analyzes 53 psychiatric morbidity 53 Renal Cell Carcinoma RCC 53 Medication adherence 53 poststroke 53 NAMCS 53 intratympanic 53 HADS 53 GH deficiency 53 underwent resection 53 Multivariate analysis 53 Fractional Flow Reserve 53 HRCT 53 Brief Psychiatric 53 FDA defined valvulopathy 53 WOMAC pain 53 nodal metastases 53 elevated CRP 53 adrenalectomy 53 thyrotropin levels 53 HIV HCV coinfected 53 tissue oxygenation 53 nephron sparing surgery 53 antiphospholipid antibodies 53 pharmacogenetic testing 53 subscales 53 mean ± SEM 53 urolithiasis 53 stratifying 53 primary aldosteronism 53 FDG PET scans 53 lipid lowering agents 53 prognostic biomarker 53 Socio demographic 53 prospectively enrolled 53 pelvic lymphadenectomy 53 Acute Physiology 53 Stroke Scale 53 Heterogeneity 53 FDG-PET/CT 53 coronary artery calcium 53 renal artery stenosis 53 logistic regression 53 DEXA scan 53 stepwise logistic regression 53 coronary stenosis 53 retrospective cohort 53 posttransplant 53 venous thromboembolic disease 53 covariance 53 nonfasting triglyceride levels 53 Outcome Measures 53 observational cohort study 53 mild renal insufficiency 53 undergoing liver transplantation 53 carotid plaques 53 hypertension diabetes mellitus 53 duplex ultrasonography 53 cerebral microbleeds 53 conducted retrospective cohort 53 guideline concordant 53 biopsychosocial 53 cerebral oximetry 53 GPRD 53 Secondary efficacy endpoints 53 % CI #.#-#.# [006] 53 Chronic Heart Failure 53 postoperative delirium 52 sd = 52 Carotid endarterectomy 52 affective disorders 52 functional gastrointestinal disorders 52 SELENA SLEDAI 52 Prognostic Index 52 Fibromyalgia Impact Questionnaire 52 GWTG 52 Renal dysfunction 52 Acute Coronary Syndromes 52 hemodynamic variables 52 Pain Rating Scale 52 Digital Mammographic Imaging 52 SLEDAI 52 hydroxyvitamin D concentrations 52 Intervention Trial 52 Global Impression CGI 52 PSADT 52 Prognostic Value 52 BEXXAR Therapeutic Regimen 52 ALSFRS R 52 haematologic 52 prospective longitudinal 52 pa tients 52 elevated transaminases 52 esophageal manometry 52 preoperative diagnosis 52 HLA DR4 52 LV ejection fraction 52 Visual Analog 52 postoperative atrial fibrillation 52 Ocular Surface Disease 52 albumin excretion 52 Abnormal Involuntary Movement 52 postintervention 52 nasal polyposis 52 underwent CABG 52 flutamide 52 TURBT 52 debulking surgery 52 CIN2 + 52 extracapsular extension 52 postoperative mortality 52 cerebrovascular accidents 52 Descriptive statistics 52 osteopenic 52 clinically localized prostate 52 Mild Cognitive Impairment 52 cystoid macular edema 52 BERKELEY CA UroToday.com 52 bioprosthetic valve 52 perioperative complications 52 preoperative intraoperative 52 LVNC 52 allogeneic hematopoietic stem cell 52 spirometric 52 neurosensory 52 coronary revascularization 52 hepatorenal syndrome 52 NICE SUGAR 52 Symptom Scale 52 VFQ 52 -#.# ± [002] 52 sociodemographic 52 histological diagnosis 52 SYNTAX trial 52 nonalcoholic steatohepatitis 52 baseline LDH 52 postoperative infections 52 alexithymia 52 interrater 52 concomitant medications 52 histopathologic 52 bivariate analysis 52 genomewide 52 atherothrombosis 52 T1DM 52 Kaplan Meier analysis 52 Framingham Risk Score 52 symptomatic intracerebral hemorrhage 52 thyroid carcinoma 52 F FDG PET 52 TT genotype 52 Neoplasms 52 semistructured interview 52 periprocedural MI 52 impaired glucose metabolism 52 bronchial hyperresponsiveness 52 Visual Analogue Scale VAS 52 thyroid nodules 52 poor metabolizers 52 postoperative radiotherapy 52 voiding dysfunction 52 seminal vesicle invasion 52 Histologic 52 KRAS mutation 52 Hemodynamic 52 Glasgow Coma Scale 52 intravenous diuretics 52 hemodialysis patients 52 Catheter Associated 52 beta blocker therapy 52 ß blockers 52 perinatal outcomes 52 Endarterectomy 52 Ischemic 52 conditional logistic regression 52 meta analytic 52 dyssynchrony 52 differential gene expression 52 oncologic outcomes 52 electrodiagnostic 52 Hopkins Symptom Checklist 52 hepatic lesions 52 demographic variables 52 Hyperlipidemia 52 myocardial viability 52 CDAI 52 Genotypic 52 PSA nadir 52 comorbid illnesses 52 thiopurine 52 antibiotic prophylaxis 52 atherothrombotic disease 52 diagnosing ADHD 52 operable breast cancer 52 undergoing radical prostatectomy 52 subsyndromal 52 MMSE 52 genotypic resistance 52 Venous thromboembolism 52 dose Iluvien 52 Neuropsychiatric Inventory NPI 52 colorectal liver metastases 52 adenoma detection 52 tracheal intubation 52 Prostate Px + 52 Posttraumatic 52 cytogenic 52 subscores 52 genotype phenotype 52 serum PSA 52 Myocardial Infarction TIMI 52 advanced neoplasia 52 CSF biomarkers 52 adenoidectomy 52 semiquantitative 51 demyelinating 51 mL/min/#.# m 2 51 subclinical disease 51 Neuropsychiatric Inventory 51 anterior temporal 51 ER CHOP 51 attain statistical significance 51 FFR measurements 51 axillary node dissection 51 stereotactic radiotherapy 51 enthesitis 51 Differential Diagnosis 51 Comorbid 51 Angiographic 51 confidence interval #.#-#.# 51 Scale EDSS 51 metaplasia 51 Depression Scale 51 bronchoalveolar lavage BAL 51 DAS# CRP 51 advanced adenomas 51 mediastinitis 51 pacemaker implantation 51 patients undergoing CABG 51 SLNB 51 noninvasive outpatient 51 PCWP 51 prospectively stratified 51 P = .# 51 visceral adiposity 51 NIHSS 51 Nonalcoholic Fatty Liver Disease 51 postmenopausal hormone 51 Intervention Effectiveness CATIE 51 hyperhomocysteinemia 51 System IPSS 51 HOMA IR 51 percutaneous drainage 51 interobserver reliability 51 estimated glomerular filtration 51 Breslow thickness 51 antibiotic regimens 51 Kaplan Meier curves 51 prostate carcinoma 51 hemodynamic measurements 51 Percutaneous Tibial Nerve Stimulation 51 Psychodynamic 51 Histological 51 adjunctively 51 angioplasty stenting 51 Lewy bodies DLB 51 SPECT MPI 51 Skin sterol 51 FACIT 51 chi squared 51 androgen deficiency 51 ABCB1 51 randomizing patients 51 Laryngeal Cancer 51 causative mutation 51 gastric adenocarcinoma 51 nonobese 51 helical CT 51 hypertension dyslipidemia 51 coinfected patients 51 predictive validity 51 tic severity 51 Dyspnea 51 microsatellite instability 51 pain subscale 51 electron beam computed tomography 51 abnormal cytology 51 p = #.# [003] 51 Crohn Disease Activity 51 biochemical recurrence 51 immunohistochemical 51 comorbid diagnoses 51 microscopic colitis 51 IQR 51 psychometric properties 51 CT perfusion 51 familial aggregation 51 somatoform disorder 51 UPDRS 51 Erectile Function 51 State Examination MMSE 51 Echocardiographic 51 thromboembolic complications 51 FFR guided 51 coronary artery calcification 51 immunocompetent 51 node metastases 51 antimicrobial prophylaxis 51 coronary CTA 51 Interrater reliability 51 cardiac computed tomography 51 calcaneal fractures 51 multiple linear regression 51 leukocyte counts 51 BENICAR HCT 51 nonpsychotic 51 EGFR mutation status 51 tipranavir r 51 HF ACTION 51 Contrast Enhanced 51 nosology 51 % CI #.#-#.# [003] 51 chronic prostatitis chronic 51 Lymph node 51 stratify 51 hyperintensities 51 FDG PET imaging 51 Ejection Fraction 51 prospective nonrandomized 51 Invasive Breast Cancer 51 % CI #.#-#.# [005] 51 FDG PET CT 51 neuropsychological assessments 51 adjuvant therapies 51 percutaneous vertebroplasty 51 revascularization procedures 51 prespecified secondary 51 SYNTAX 51 nomogram 51 renal cysts 51 conventional angiography 51 STEP BD 51 posttreatment 51 wedge resection 51 nonpsychiatric 51 carotid endarterectomy 51 allele frequencies 51 QRS duration 51 chorioamnionitis 51 null responder 51 lowest tertile 51 mutated K ras 51 albumin excretion rate 51 postoperative pulmonary 51 varicoceles 51 SSc 51 GWTG CAD 51 Subsets 51 Framingham Offspring 51 prognostic significance 51 apnea hypopnea index 51 Coronary Artery Bypass Grafting 51 cTnI 51 abdominal adiposity 51 co morbidities 51 stage IIIA 51 NYHA classification 51 deCODE BreastCancer TM 51 linear regression analyzes 51 BSIs 51 Suicidal ideation 51 comorbid 51 sacral neuromodulation 51 hip BMD 51 ovarian malignancy 51 PHQ 9 51 Functional Outcomes 51 Postoperative complications 51 MELD scores 51 recursive partitioning 51 Genetic Markers 51 comorbid psychiatric disorders 51 BRCA1 BRCA2 51 clinicopathological features 51 antidiabetic medication 51 randomized controlled trials RCTs 51 epoetin alpha 51 Genomic Grade 51 State Exam MMSE 51 pharmacologic treatments 51 laser Doppler 51 HAQ DI 51 benign paroxysmal positional vertigo 51 shorter telomere length 51 arterial thromboembolism 51 endometrial thickness 51 Perfusion 51 etiologic factors 51 Multiple logistic regression 51 artery stenosis 51 Surgical resection 51 ADAS Cog 51 plasma creatinine 51 symptomatology 51 QIDS SR 50 serum estradiol 50 FDG PET 50 docetaxel pretreated 50 radical cystectomy 50 preoperative staging 50 HIPEC 50 nonfatal myocardial infarction MI 50 Ventricular Arrhythmias 50 Clinical Outcome 50 antithrombotic therapy 50 geriatric syndromes 50 multivariable 50 medication nonadherence 50 RARP 50 Preoperative 50 diabetes hypertension hyperlipidemia 50 Kruskal Wallis test 50 specific antigen PSA 50 polyarticular 50 chlamydial infection 50 interquartile range 50 Stratification 50 lymphadenectomy 50 Cardiorespiratory fitness 50 Adverse Event 50 MDQ 50 esophageal carcinoma 50 Glomerular Filtration Rate 50 euthymic 50 perioperative mortality 50 ADCS CGIC 50 Subgroup analysis 50 arterial calcification 50 somatic symptoms 50 histologically confirmed 50 syndromal 50 regression analyzes 50 prospective observational cohort 50 ACI TIPI 50 metaanalysis 50 subclinical hypothyroidism 50 Polysomnography 50 carcinomatosis 50 prospective multicenter study 50 covariates 50 GBA mutations 50 EURIDIS 50 glomerular filtration 50 logistic regressions 50 schizophrenia schizoaffective disorder 50 pre operatively 50 MSLT 50 Practice Patterns 50 ADAS cog 50 serum GGT 50 vestibular rehabilitation 50 antiretroviral naïve 50 Ischaemic 50 tonsillar hypertrophy 50 systolic dysfunction 50 transcranial Doppler ultrasound 50 Hippocampal 50 Bacteremia 50 Helicobacter pylori eradication 50 ultrasonographic 50 anthropometric measures 50 Ultrasonography 50 TRUS 50 gene polymorphisms 50 carotid artery stenosis 50 Carotid Artery Stenting 50 eNO 50 immunohistochemical analysis 50 Depression Scale HADS 50 haematuria 50 cortical atrophy 50 preoperative 50 Estrogen Receptor 50 empiric treatment 50 undergone radical prostatectomy 50 DXA scan 50 Adjuvant chemotherapy 50 HNSCC 50 Tyrosine Kinase Inhibitors 50 percutaneous biopsy 50 perioperative morbidity 50 Diagnostic Criteria 50 arteriography 50 morphometry 50 Patient Registry 50 UA NSTEMI 50 histopathologic findings 50 revascularized 50 Geriatric Depression 50 myocardial infarction MI 50 MADRS score 50 leukocytosis 50 hypochondriasis 50 vWD 50 atypical hyperplasia 50 core needle biopsies 50 % CI #.#-#.# [007] 50 ROC curves 50 Quality Indicators 50 Kaplan Meier curve 50 coagulation abnormalities 50 preoperatively 50 dosimetric 50 laparoscopic bariatric surgery 50 intraclass correlation coefficient 50 arterial oxygen saturation 50 socioeconomic variables 50 CYP#D# genotype 50 ECG gated 50 generalizability 50 Rating Scale MADRS 50 cognitive affective 50 socio demographic 50 Index CDAI 50 Mammographic 50 prognostically 50 femoral neck fracture 50 KCCQ 50 Socioeconomic status 50 affective psychoses 50 metabolic syndrome MetS 50 liver resection 50 elevated fasting glucose 50 euthyroid 50 polygenic 50 ECOG PS 50 Subtypes 50 Carotid Revascularization Endarterectomy vs. 50 nonadherence 50 carotid intima media 50 prospective multicentre 50 exhaled nitric oxide 50 genomic alterations 50 LRTI 50 hepatic cirrhosis 50 ACUITY trial 50 Heavy menstrual bleeding 50 LUTS 50 MSCT 50 coronary angiography 50 thromboprophylaxis 50 nonfatal MI 50 pathophysiological mechanisms 50 genomic biomarker 50 RECIST Response Evaluation Criteria 50 Percutaneous Coronary Interventions 50 cerebral oxygenation 50 hsCRP 50 ipsilateral stroke 50 Recurrent Stroke 50 Bioavailability 50 Pharmacologic 50 empirically derived 50 Coronary Calcium 50 Sonographic 50 Atopic Dermatitis 50 #q# deletion syndrome 50 endocervical 50 surrogate markers 50 elevated creatinine 50 Ischemic Stroke 50 Meta Analyses 50 hepatic resection 50 meta analytic review 50 INVEGA ® 50 EoE 50 Health Questionnaire PHQ 50 rheumatoid factor 50 adenomatous polyps 50 electroencephalographic 50 resectable pancreatic cancer 50 stable angina 50 supratentorial 50 Rating Scale UPDRS 50 Reperfusion Injury 50 OSAHS 50 ß = 50 Roxana Mehran MD 50 Coronary artery calcium 50 rebleeding 50 Epworth Sleepiness Scale 50 #q# deletion 50 postoperative infection 50 multivariate adjusted 50 Doppler sonography 50 cardioembolic stroke 50 treat NNT 50 pairwise comparisons 50 radiotherapy RT 50 locoregional recurrence 50 nonischemic 50 Heart Rate Variability 50 serum lipid 50 external beam radiotherapy 50 methotrexate monotherapy 50 hyperinsulinemic 50 chronicity 50 Coronary Angiography 50 gastric carcinoma 50 chemoprevention trials 50 NSABP B 50 Group RTOG 50 cytoreductive nephrectomy 50 multicentric 50 eGFR 50 coronary calcification 50 prognostic factors 50 femoral neck BMD 50 Confidence Interval 50 VAD implantation 50 lymphoproliferative disorders 50 BPRS 50 glomerular filtration rate 50 cardiac perfusion 50 femoral neck fractures 50 Tasigna prolongs 50 #-# Full Text 50 renal tumors 50 Watchful Waiting 50 thetreatment 50 ILLUSTRATE 50 nonparametric 50 Psychosomatic Research 50 elevated homocysteine 50 HEDIS R 50 WOMAC scores 50 Erythropoiesis Stimulating Agents ESAs 50 hypercoagulable 50 intracerebral haemorrhage 50 sleeve lobectomy 50 diagnostic modality 50 cirrhotic patients 50 postoperative morbidity 50 CI = 50 pyridostigmine 50 pulmonary dysfunction 50 noncancer 50 BioZ ICG 50 nonpharmacologic 50 bacterial prostatitis 50 IIEF 50 pancreatectomy 50 Pearson correlation coefficient 50 Electrophysiological 50 acetabular dysplasia 50 lymphocyte count 49 chemoradiation therapy 49 intravenous tPA 49 white matter hyperintensities 49 chest radiographs 49 interquartile range IQR 49 Pelvic Organ Prolapse 49 linear regression models 49 Common Terminology Criteria 49 immunosuppressive regimen 49 Patients Receiving 49 radical retropubic prostatectomy 49 transabdominal 49 risk stratification 49 unstable angina pectoris 49 aneurysmal 49 K ras mutations 49 acetabular fracture 49 pancreatic resection 49 ANOVA 49 sensitivity specificity 49 antenatal corticosteroids 49 empiric 49 Coronary artery bypass 49 Diabetic Foot Ulcer 49 silent ischemia 49 Hemodialysis Patients 49 aromatase inhibitor therapy 49 p = .# [002] 49 systolic hypertension 49 psychoeducation 49 Meta Analysis 49 liver histology 49 Depressive Symptoms 49 pulsatility index 49 visceral metastases 49 carotid artery narrowing 49 carotid revascularization 49 unicompartmental knee arthroplasty 49 Immunohistochemistry 49 Hospitalized Patients 49 esophageal reflux 49 observational cohort 49 atopic asthma 49 Breast Carcinoma 49 prophylactic cranial irradiation 49 Psoriasis Area 49 PANSS 49 acute subacute 49 ICD shocks 49 tumor subtype 49 AMOR IPAT 49 unfavorable cytogenetics 49 Solid Tumors 49 Sexual Function 49 TRAS 49 chronic hemodialysis

Back to home page